Association between serum uric acid level and non-alcoholic fatty liver disease in Koreans

[1] Williams CD, Stengel J, Asike MI, Torres DM, Shaw J, Contreras M, et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology. 2011; 140:124–31. WilliamsCD StengelJ AsikeMI TorresDM ShawJ ContrerasM Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study Gastroenterology 2011 140 124 31 10.1053/j.gastro.2010.09.03820858492 Search in Google Scholar

[2] Speliotes EK, Massaro JM, Hoffmann U, Vasan RS, Meigs JB, Sahani DV, et al. Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: the Framingham Heart Study. Hepatology. 2010; 51:1979–87. SpeliotesEK MassaroJM HoffmannU VasanRS MeigsJB SahaniDV Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: the Framingham Heart Study Hepatology 2010 51 1979 87 10.1002/hep.23593302316020336705 Search in Google Scholar

[3] Bae JC, Cho YK, Lee WY, Seo HI, Rhee EJ, Park SE, et al. Impact of nonalcoholic fatty liver disease on insulin resistance in relation to HbA1c levels in nondiabetic subjects. Am J Gastroenterol. 2010; 105:2389–95. BaeJC ChoYK LeeWY SeoHI RheeEJ ParkSE Impact of nonalcoholic fatty liver disease on insulin resistance in relation to HbA1c levels in nondiabetic subjects Am J Gastroenterol 2010 105 2389 95 10.1038/ajg.2010.27520628364 Search in Google Scholar

[4] Park SH, Jeon WK, Kim SH, Kim HJ, Park DI, Cho YK, et al. Prevalence and risk factors of non alcoholic fatty liver disease among Korean adults. J Gastroenterol Hepatol. 2006; 21:138–43. ParkSH JeonWK KimSH KimHJ ParkDI ChoYK Prevalence and risk factors of non alcoholic fatty liver disease among Korean adults J Gastroenterol Hepatol 2006 21 138 43 10.1111/j.1440-1746.2005.04086.x16706825 Search in Google Scholar

[5] Sirota JC, McFann K, Targher G, Johnson RJ, Chonchol M, Jalal DI. Elevated serum uric acid levels are associated with non-alcoholic fatty liver disease independently of metabolic syndrome features in the United States: liver ultrasound data from the National Health and Nutrition Examination Survey. Metabolism. 2013; 62:392–9. SirotaJC McFannK TargherG JohnsonRJ ChoncholM JalalDI Elevated serum uric acid levels are associated with non-alcoholic fatty liver disease independently of metabolic syndrome features in the United States: liver ultrasound data from the National Health and Nutrition Examination Survey Metabolism 2013 62 392 9 10.1016/j.metabol.2012.08.013356504723036645 Search in Google Scholar

[6] Lu Z-Y, Shao Z, Li Y-L, Wulasihan M, Chen X-H. Prevalence of and risk factors for non-alcoholic fatty liver disease in a Chinese population: an 8-year follow-up study. World J Gastroenterol. 2016; 22:3663–9. LuZ-Y ShaoZ LiY-L WulasihanM ChenX-H Prevalence of and risk factors for non-alcoholic fatty liver disease in a Chinese population: an 8-year follow-up study World J Gastroenterol 2016 22 3663 9 10.3748/wjg.v22.i13.3663481465227053858 Search in Google Scholar

[7] Feig DI, Kang D-H, Johnson RJ. Uric acid and cardiovascular risk. N Eng J Med. 2008; 359:1811–21. FeigDI KangD-H JohnsonRJ Uric acid and cardiovascular risk N Eng J Med 2008 359 1811 21 10.1056/NEJMra0800885268433018946066 Search in Google Scholar

[8] Lee JW, Cho YK, Ryan M, Kim H, Lee SW, Chang E, et al. Serum uric acid as a predictor for the development of nonalcoholic fatty liver disease in apparently healthy subjects: a 5-year retrospective cohort study. Gut Liver. 2010; 4:378–83. LeeJW ChoYK RyanM KimH LeeSW ChangE Serum uric acid as a predictor for the development of nonalcoholic fatty liver disease in apparently healthy subjects: a 5-year retrospective cohort study Gut Liver 2010 4 378 83 10.5009/gnl.2010.4.3.378295635220981217 Search in Google Scholar

[9] Ryu S, Chang Y, Zhang Y, Kim S-G, Cho J, Son HJ, et al. A cohort study of hyperuricemia in middle-aged South Korean men. Am J Epidemiol. 2012; 175:133–43. RyuS ChangY ZhangY KimS-G ChoJ SonHJ A cohort study of hyperuricemia in middle-aged South Korean men Am J Epidemiol 2012 175 133 43 10.1093/aje/kwr29122156041 Search in Google Scholar

[10] Petta S, Camma C, Cabibi D, Di Marco V, Craxì A. Hyperuricemia is associated with histological liver damage in patients with non alcoholic fatty liver disease. Aliment Pharmacol Ther. 2011; 34:757–66. PettaS CammaC CabibiD Di MarcoV CraxìA Hyperuricemia is associated with histological liver damage in patients with non alcoholic fatty liver disease Aliment Pharmacol Ther 2011 34 757 66 10.1111/j.1365-2036.2011.04788.x21790685 Search in Google Scholar

[11] Ballestri S, Nascimbeni F, Romagnoli D, Lonardo A. The independent predictors of non-alcoholic steatohepatitis and its individual histological features. Insulin resistance, serum uric acid, metabolic syndrome, alanine aminotransferase and serum total cholesterol are a clue to pathogenesis and candidate targets for treatment. Hepatol Res. 2016; 46:1074–87. BallestriS NascimbeniF RomagnoliD LonardoA The independent predictors of non-alcoholic steatohepatitis and its individual histological features. Insulin resistance, serum uric acid, metabolic syndrome, alanine aminotransferase and serum total cholesterol are a clue to pathogenesis and candidate targets for treatment Hepatol Res 2016 46 1074 87 10.1111/hepr.1265626785389 Search in Google Scholar

[12] Sandra S, Lesmana CRA, Purnamasari D, Kurniawan J, Gani RA. Hyperuricemia as an independent risk factor for non-alcoholic fatty liver disease (NAFLD) progression evaluated using controlled attenuation parameter-transient elastography: lesson learnt from tertiary referral center. Diabetes Metab Syndr. 2019; 13:424–8. SandraS LesmanaCRA PurnamasariD KurniawanJ GaniRA Hyperuricemia as an independent risk factor for non-alcoholic fatty liver disease (NAFLD) progression evaluated using controlled attenuation parameter-transient elastography: lesson learnt from tertiary referral center Diabetes Metab Syndr 2019 13 424 8 10.1016/j.dsx.2018.10.00130641737 Search in Google Scholar

[13] von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP; STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Bull World Health Organ. 2007; 85:867–72. von ElmE AltmanDG EggerM PocockSJ GøtzschePC VandenbrouckeJP STROBE Initiative The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies Bull World Health Organ 2007 85 867 72 10.1097/EDE.0b013e318157765418049194 Search in Google Scholar

[14] Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A, Tiribelli C. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006; 6:33. doi: 10.1186/1471-230X-6-33 BedogniG BellentaniS MiglioliL MasuttiF PassalacquaM CastiglioneA TiribelliC The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population BMC Gastroenterol 2006 6 33 10.1186/1471-230X-6-33 163665117081293 Open DOISearch in Google Scholar

[15] Hagström H, Nasr P, Ekstedt M, Stål P, Hultcrantz R, Kechagias S. Accuracy of noninvasive scoring systems in assessing risk of death and liver-related endpoints in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2019; 17:1148–56.e4. doi: 10.1016/j.cgh.2018.11.030 HagströmH NasrP EkstedtM StålP HultcrantzR KechagiasS Accuracy of noninvasive scoring systems in assessing risk of death and liver-related endpoints in patients with nonalcoholic fatty liver disease Clin Gastroenterol Hepatol 2019 17 1148 56.e4 10.1016/j.cgh.2018.11.030 30471458 Open DOISearch in Google Scholar

[16] McPherson S, Hardy T, Dufour J-F, Petta S, Romero-Gomez M, Allison M, et al. Age as a confounding factor for the accurate non-invasive diagnosis of advanced NAFLD fibrosis. Am J Gastroenterol. 2017; 112:740–51. McPhersonS HardyT DufourJ-F PettaS Romero-GomezM AllisonM Age as a confounding factor for the accurate non-invasive diagnosis of advanced NAFLD fibrosis Am J Gastroenterol 2017 112 740 51 10.1038/ajg.2016.453541856027725647 Search in Google Scholar

[17] Grant EG. Liver. In: Mittelstaedt CA, editor. General ultrasound. New York: Churchill Livingstone; 1992, pp. 173–248. GrantEG Liver In: MittelstaedtCA editor. General ultrasound New York Churchill Livingstone 1992 173 248 Search in Google Scholar

[18] Li C, Hsieh M-C, Chang S-J. Metabolic syndrome, diabetes, and hyperuricemia. Curr Opin Rheumatol. 2013; 25:210–6. LiC HsiehM-C ChangS-J Metabolic syndrome, diabetes, and hyperuricemia Curr Opin Rheumatol 2013 25 210 6 10.1097/BOR.0b013e32835d951e23370374 Search in Google Scholar

[19] Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018; 67:328–57. ChalasaniN YounossiZ LavineJE CharltonM CusiK RinellaM The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases Hepatology 2018 67 328 57 10.1002/hep.2936728714183 Search in Google Scholar

[20] Korean Association for the Study of the Liver (KASL). KASL clinical practice guidelines: management of nonalcoholic fatty liver disease. Clin Mol Hepatol. 2013; 19:325–48. Korean Association for the Study of the Liver (KASL) KASL clinical practice guidelines: management of nonalcoholic fatty liver disease Clin Mol Hepatol 2013 19 325 48 10.3350/cmh.2013.19.4.325389443224459637 Search in Google Scholar

[21] Fernández Rodríguez CM, Aller R, Gutiérrez García ML, Ampuero J, Gómez-Camarero J, Martín-Mateos RM, et al. Higher levels of serum uric acid influences hepatic damage in patients with non-alcoholic fatty liver disease (NAFLD). Rev Esp Enferm Dig. 2019; 111:264–9. [in English] Fernández RodríguezCM AllerR Gutiérrez GarcíaML AmpueroJ Gómez-CamareroJ Martín-MateosRM Higher levels of serum uric acid influences hepatic damage in patients with non-alcoholic fatty liver disease (NAFLD) Rev Esp Enferm Dig 2019 111 264 9 [in English] 10.17235/reed.2019.5965/201830810330 Search in Google Scholar

[22] Jaruvongvanich V, Ahuja W, Wirunsawanya K, Wijarnpreecha K, Ungprasert P. Hyperuricemia is associated with nonalcoholic fatty liver disease activity score in patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2017; 29:1031–5. JaruvongvanichV AhujaW WirunsawanyaK WijarnpreechaK UngprasertP Hyperuricemia is associated with nonalcoholic fatty liver disease activity score in patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis Eur J Gastroenterol Hepatol 2017 29 1031 5 10.1097/MEG.000000000000093128639970 Search in Google Scholar

[23] Jaruvongvanich V, Ahuja W, Wijarnpreecha K, Ungprasert P. Hyperuricemia is not associated with severity of liver fibrosis in patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2017; 29:694–7. JaruvongvanichV AhujaW WijarnpreechaK UngprasertP Hyperuricemia is not associated with severity of liver fibrosis in patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis Eur J Gastroenterol Hepatol 2017 29 694 7 10.1097/MEG.000000000000086528252464 Search in Google Scholar

[24] Yoneda M, Thomas E, Sumida Y, Imajo K, Hyogo H, Fujii H, et al. Uric acid levels decrease with fibrosis progression in patients with nonalcoholic fatty liver disease. Clin Biochem. 2014; 47:1138–9. YonedaM ThomasE SumidaY ImajoK HyogoH FujiiH Uric acid levels decrease with fibrosis progression in patients with nonalcoholic fatty liver disease Clin Biochem 2014 47 1138 9 10.1016/j.clinbiochem.2014.04.02624797484 Search in Google Scholar

[25] Sertoglu E, Ercin CN, Celebi G, Gurel H, Kayadibi H, Genc H, et al. The relationship of serum uric acid with non-alcoholic fatty liver disease. Clin Biochem. 2014; 47:383–8. SertogluE ErcinCN CelebiG GurelH KayadibiH GencH The relationship of serum uric acid with non-alcoholic fatty liver disease Clin Biochem 2014 47 383 8 10.1016/j.clinbiochem.2014.01.02924525254 Search in Google Scholar

[26] Ayonrinde OT, Olynyk JK, Beilin LJ, Mori TA, Pennell CE, de Klerk N, et al. Gender-specific differences in adipose distribution and adipocytokines influence adolescent nonalcoholic fatty liver disease. Hepatology. 2011; 53:800–9. AyonrindeOT OlynykJK BeilinLJ MoriTA PennellCE de KlerkN Gender-specific differences in adipose distribution and adipocytokines influence adolescent nonalcoholic fatty liver disease Hepatology 2011 53 800 9 10.1002/hep.2409721374659 Search in Google Scholar

[27] Lanaspa MA, Sanchez-Lozada LG, Choi YJ, Cicerchi C, Kanbay M, Roncal-Jimenez CA, et al. Uric acid induces hepatic steatosis by generation of mitochondrial oxidative stress: potential role in fructose-dependent and -independent fatty liver. J Biol Chem. 2012; 287:40732–44. LanaspaMA Sanchez-LozadaLG ChoiYJ CicerchiC KanbayM Roncal-JimenezCA Uric acid induces hepatic steatosis by generation of mitochondrial oxidative stress: potential role in fructose-dependent and -independent fatty liver J Biol Chem 2012 287 40732 44 10.1074/jbc.M112.399899350478623035112 Search in Google Scholar

[28] Choi Y-J, Shin H-S, Choi HS, Park J-W, Jo I, Oh E-S, et al. Uric acid induces fat accumulation via generation of endoplasmic reticulum stress and SREBP-1c activation in hepatocytes. Lab Invest. 2014; 94:1114–25. ChoiY-J ShinH-S ChoiHS ParkJ-W JoI OhE-S Uric acid induces fat accumulation via generation of endoplasmic reticulum stress and SREBP-1c activation in hepatocytes Lab Invest 2014 94 1114 25 10.1038/labinvest.2014.9825111690 Search in Google Scholar

[29] Johnson RJ, Nakagawa T, Sanchez-Lozada LG, Shafiu M, Sundaram S, Le M, et al. Sugar, uric acid, and the etiology of diabetes and obesity. Diabetes. 2013; 62:3307–15. JohnsonRJ NakagawaT Sanchez-LozadaLG ShafiuM SundaramS LeM Sugar, uric acid, and the etiology of diabetes and obesity Diabetes 2013 62 3307 15 10.2337/db12-1814378148124065788 Search in Google Scholar

[30] Vilar-Gomez E, Chalasani N. Non-invasive assessment of non-alcoholic fatty liver disease: clinical prediction rules and blood-based biomarkers. J Hepatol. 2018; 68:305–15. Vilar-GomezE ChalasaniN Non-invasive assessment of non-alcoholic fatty liver disease: clinical prediction rules and blood-based biomarkers J Hepatol 2018 68 305 15 10.1016/j.jhep.2017.11.01329154965 Search in Google Scholar